Cromodata, a secure Real World Data (RWD) platform focused on transforming healthcare in Latin America, has successfully secured $1,200,000 in investment capital from investors. This funding round underscores growing confidence in the company's mission to enhance healthcare systems across the region through data-driven innovation.
The company specializes in connecting clinics, pharmaceutical companies, and tech innovators by providing structured, anonymized health data. This data adheres to stringent global standards, including HIPAA and ISO, ensuring both integrity and privacy. Cromodata's platform is designed to accelerate the development of artificial intelligence, improve early diagnostics, and ultimately help health systems in Latin America become more self-sustaining. Currently, Cromodata boasts a significant footprint with over 19 million DICOM images and a network spanning 47 healthcare centers throughout LATAM, offering the scale necessary for impactful research and development.
This newly acquired capital is earmarked to significantly bolster Cromodataโs operational capabilities and fuel its strategic growth initiatives. The company plans to use the funds to further enhance its platform technology, expand its network of connected healthcare providers, and strengthen its capacity to deliver high-quality, ethically sourced data to researchers and innovators. This investment will enable Cromodata to deepen its impact by bridging the crucial gap between those who generate health data and those who need it to drive smarter, evidence-based decisions.
Looking ahead, Cromodata is committed to leveraging this investment to solidify its position as a leading force in healthcare data solutions in Latin America. The company aims to continue unlocking the ethical and effective value of health data, furthering its goal of reimagining the future of health outcomes across the continent.
